A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT07154290 · RECRUITING
Trial details
- NCT number
- NCT07154290
- Sponsor
- Regeneron Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-18
- Primary completion
- 2030-06-10
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.